In August 2011, the Centers for Disease Control and Prevention (CDC) released new estimates of the annual number of new HIV infections (HIV incidence) in the United States. The estimates, for 2006 through 2009, are the first multiyear estimates using CDC’s national HIV incidence surveillance methodology, which is based on direct measurement of new HIV infections using a laboratory test that can classify new diagnoses as either recent or long-standing HIV infections. The new estimates suggest that overall HIV incidence in the United States has been relatively stable and also underscore some key HIV prevention challenges that require urgent action.
ICF’s HIV/AIDS portfolio combines the expertise of hundreds of public health, information technology, behavioral science, cultural competence, technical assistance and capacity building, substance abuse and mental health, and other professionals necessary for successful HIV/AIDS related programs and activities. We have a long and continuing relationship with the CDC and its domestic and international projects. CDC recently awarded ICF $1,117,110 to continue support of the National HIV Prevention Program Monitoring and Evaluation Service Center.
ICF has also been participating in the U.S. Agency for International Development (USAID) Demographic and Health Surveys (DHS) program for more than two decades and was recently awarded a $2.7 million contract to conduct an Independent Evaluation of the Affordable Medicines Facility Malaria Phase 1 for The Global Fund to Fight AIDS, Tuberculosis, and Malaria (Global Fund).